All of the following statements about hybridoma technology are true, EXCEPT:
Specific antibody producing cells are integrated with myeloma cells Myeloma cells with mutation salvage pathway grows well in HAT medium. Aminopterin, a folate antagonist, inhibits de novo pathway HGPase and thymidylate synthetase are required for salvage pathway